A previous 18F-flortaucipir PET study that included a PiD case reported that, although AT8 immunohistochemistry revealed a high tau burden in the temporal and parietal lobes of the case, 18F-flortaucipir uptake remained relatively uniform across brain regions, suggesting its limited sensitivity to 3R tau [24]. This evidence concerns the gene MAPT and pelvic inflammatory disease.